The future of basal insulin

Diabetes Technol Ther. 2013 Sep;15(9):727-32. doi: 10.1089/dia.2013.0228. Epub 2013 Aug 21.
No abstract available

Publication types

  • Editorial
  • Historical Article

MeSH terms

  • Animals
  • Biosimilar Pharmaceuticals
  • Chemistry, Pharmaceutical
  • Delayed-Action Preparations
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / history*
  • Dogs
  • History, 20th Century
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / history*
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / administration & dosage
  • Insulin / history*
  • Insulin / therapeutic use*
  • Insulin Detemir
  • Insulin Glargine
  • Insulin Infusion Systems
  • Insulin, Isophane / therapeutic use
  • Insulin, Long-Acting / therapeutic use
  • Swine

Substances

  • Biosimilar Pharmaceuticals
  • Delayed-Action Preparations
  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • Insulin Glargine
  • Insulin Detemir
  • Insulin, Isophane
  • insulin degludec